New-Onset Diabetes in Covid-19

Francesco Rubino, Stephanie A. Amiel, Paul Zimmet, George Alberti, Stefan Bornstein, Robert H. Eckel, Geltrude Mingrone, Bernhard Boehm, Mark E. Cooper, Zhonglin Chai, Stefano Del Prato, Linong Ji, David Hopkins, William H. Herman, Kamlesh Khunti, Jean-Claude Mbanya

Research output: Contribution to journalArticle

160 Citations (SciVal)

Abstract

There is a bidirectional relationship between Covid-19 and diabetes. On the one hand, diabetes is associated with an increased risk of severe Covid-19. On the other hand, new-onset diabetes and severe metabolic complications of preexisting diabetes, including diabetic ketoacidosis and hyperosmolarity for which exceptionally high doses of insulin are warranted, have been observed in patients with Covid-19.1-3 These manifestations of diabetes pose challenges in clinical management and suggest a complex pathophysiology of Covid-19–related diabetes.
Original languageEnglish
Pages (from-to)789-791
Number of pages3
JournalTHE NEW ENGLAND JOURNAL OF MEDICINE
Volume383
DOIs
Publication statusPublished - 2020

Keywords

  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections
  • Diabetes Complications
  • Diabetes Mellitus
  • Global Health
  • Glucose
  • Humans
  • Pandemics
  • Pneumonia, Viral
  • Registries
  • SARS-CoV-2

Fingerprint

Dive into the research topics of 'New-Onset Diabetes in Covid-19'. Together they form a unique fingerprint.

Cite this